US HB7567 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on July 9 2020 - 25% progression, died in committee
Action: 2020-07-09 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 9 2020 - 25% progression, died in committee
Action: 2020-07-09 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.
Title
Helping Experts Accelerate Rare Treatments Act of 2020
Sponsors
Rep. Paul Tonko [D-NY] | Rep. David McKinley [R-WV] | Rep. Michael San Nicolas [D-GU] |
History
Date | Chamber | Action |
---|---|---|
2020-07-09 | House | Referred to the House Committee on Energy and Commerce. |
2020-07-09 | House | Introduced in House |
Subjects
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug therapy
European Union
Government information and archives
Government studies and investigations
Health
Health care coverage and access
Health information and medical records
Licensing and registrations
Prescription drugs
Drug safety, medical device, and laboratory regulation
Drug therapy
European Union
Government information and archives
Government studies and investigations
Health
Health care coverage and access
Health information and medical records
Licensing and registrations
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/7567/all-info |
Text | https://www.congress.gov/116/bills/hr7567/BILLS-116hr7567ih.pdf |